Vigil Neuroscience Inc. (VIGL) - Uzoq muddatli majburiyatlarning kapitalga nisbati

Vigil Neuro - VIGL emitenti grafik logotipi

Vigil Neuroscience (VIGL) mikrogliyalarni nishonga olishga e'tibor qaratgan holda, Altsgeymer kasalligiga qarshi kurashish uchun zamonaviy molekulalarni ishlab chiqmoqda. GURU.Markets platformasidagi narxlar dinamikasi tarixi, u yerda ko'rsatkich 0.29 darajasida turibdi, ilmiy muvaffaqiyatni dori vositalarini kashf etishni tezlashtirish uchun avtomatlashtirilgan skriningni joriy etish bilan bog'laydi. Biznes barqarorligi neyroimmunologlarning kuchli iste'dodlar zaxirasi va global sinov rahbarlarining aniq tanlanishi orqali ta'minlanadi, bu esa asosiy mutaxassislarning yo'qotilishining oldini oladi.

vigilneuro.com (VIGL): Uzoq muddatli qarzning o'z kapitaliga nisbati 04.07.2022dan 16.08.2025gacha

Vigil Neuroscience Inc. (VIGL) kompaniyasining tahliliy kesimlari

- joriy narx va aksiyalarning prognoz qilingan qiymati:
Aksiya kursi Vigil Neuro|VIGL - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi ko'rsatkichlari:
Bozor qiymati Vigil Neuroscience, Inc.|VIGL - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- xususiy kapitalning balans qiymati ko'rsatkichlari:
Bitta aksiya hisobiga balans qiymati Vigil Neuroscience|VIGL - Kompaniyaning balans qiymati|Balans qiymatiga nisbatan bozor qiymati vigilneuro.com|VIGL - Kompaniyaning jami aktivlari
- qarz majburiyatlari va likvidlik statistikasi:
Qarzning kapitalga nisbati Vigil Neuroscience|VIGL - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Vigil Neuro|VIGL - Kompaniyaning jamlangan qarzlari|Sof aktivlarga qarzlar Vigil Neuroscience, Inc.|VIGL - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarzdorlik Vigil Neuroscience|Oraliq qoplama koeffitsiyenti vigilneuro.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
VIGL - Kompaniyaning sof foydasi
Kompaniyaning jamlanma tahlili:Vigil Neuroscience
Vigil Neuro original mahsuloti

Vigil Neuroscience kompaniyasining ensefalopatiya davolashdagi monopoliya salohiyati tadqiqotlar va ishlanmalarga ( R&D ) sezilarli investitsiyalarni talab qiladi. Ushbu ko'rsatkich bir yildan ortiq muddatli majburiyatlarni aksiyadorlar kapitalining umumiy qiymati bilan solishtiradi. U biznesning moliyaviy avtonomiya darajasini va tashqi moliyalashtirishga bog'liqlik xavfini aniqlaydi. Qarzni minimallashtirish xarajatlarni kamaytiradi, ammo kengayishni sekinlashtirishi mumkin. Uzoq muddatli majburiyatlarning kapitalga nisbatini tahlil qilish orqali investor kapital tuzilmasining barqarorligini baholaydi.

Muhim raqobatchilar

Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi BIIB (Biogen Inc)|Uzoq muddatli qarzning kapitalga nisbati NBIX|RGC - Uzoq muddatli majburiyatlarning kapitalga nisbati|Axsome Therapeutics - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati acadia-pharm.com ACAD|XENE - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti VKTX (Viking Therapeutics Inc)|Supernus Pharma (SUPN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Catalyst Corp (CPRX)|Uzoq muddatli qarzning o'z kapitaliga nisbati DNLI|Uzoq muddatli qarzning o'z kapitaliga nisbati HRMY|Uzoq muddatli qarzning kapitalga nisbati BHVN|Uzoq muddatli qarzdorlikning kapitalga nisbati Amylyx Pharmaceuticals Inc|Uzoq muddatli qarzning kapitalga nisbati TRVI (Trevi Pharma)|Uzoq muddatli qarzdorlikning o'z kapitaliga nisbati Praxis Corp|Anavex Life Sciences - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati ceribell.com CBLL|Prothena Corp (PRTA) - Uzoq muddatli qarzning o'z kapitaliga nisbati|ALEC (Alector) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati ANNX|OMER: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Neurogene Inc. (NGNE)|acimmune.com - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati VYGR (Voyager Therapeutics, Inc.)|Neumora (NMRA) - Uzoq muddatli majburiyatlarning kapitalga nisbati|SCLX: Uzoq muddatli qarzning o'z kapitaliga nisbati|TVGN - Uzoq muddatli qarzning kapitalga nisbati|alphacognition.com (ACOG) - Uzoq muddatli qarzning o'z kapitaliga nisbati|cogrx.com - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Inhibikase Therapeutics, Inc.|Uzoq muddatli majburiyatlarning kapitalga nisbati Cassava Sciences Inc SAVA|Uzoq muddatli qarzning o'z kapitaliga nisbati Assertio Holdings, Inc. (ASRT)|Uzoq muddatli qarzdorlikning kapitalga nisbati coyatherapeutics.com|Uzoq muddatli qarzning kapitalga nisbati VTGN (Vistagen)|OVID - Uzoq muddatli qarzning o'z kapitaliga nisbati|Acumen Pharmaceuticals, Inc. - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati CervoMed, Inc. CRVO|ATHE: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Clene (CLNN)|Uzoq muddatli qarzning o'z kapitaliga nisbati PepGen Inc|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi JUNS (jupiterneurosciences.com)|Uzoq muddatli qarzning kapitalga nisbati RLMD|Uzoq muddatli qarzning o'z kapitaliga nisbati Annovis Bio Inc ANVS|Uzoq muddatli qarzning kapitalga nisbati GRCE (Grace Therapeutics)|Firefly Neuro (AIFF) - Uzoq muddatli majburiyatlarning kapitalga nisbati|KLTO: Uzoq muddatli qarzning o'z kapitaliga nisbati|NRSN: Uzoq muddatli qarzning o'z kapitaliga nisbati|RVPH: Uzoq muddatli qarzning kapitalga nisbati|MTVA - Uzoq muddatli qarzdorlikning kapitalga nisbati|NRXS (NeurAxis, Inc) - Uzoq muddatli qarzning kapitalga nisbati|HSDT - Uzoq muddatli qarzdorlikning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Passage Bio, Inc. (PASG)|Uzoq muddatli qarzning o'z kapitaliga nisbati NEUP (bionomics.com.au)|Uzoq muddatli qarzning o'z kapitaliga nisbati Minerva Neurosciences, Inc. NERV|ATHA: Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Addex Therapeutics, Ltd. - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Alzamend Neuro, Inc.|CYCN (cyclerion.com) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Protagenic Therapeutics, Inc. (PTIX) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Pasithea Therapeutics Corp|CRGT: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Avenue Therapeutics, Inc (ATXI)|BCLI - Uzoq muddatli majburiyatlarning kapitalga nisbati|Cara Therapeutics, Inc. - Uzoq muddatli qarzning o'z kapitaliga nisbati|chromocell.com - Uzoq muddatli qarzning o'z kapitaliga nisbati|Eliem - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati Intra-Cellular Therapies ITCI|LBPH: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning o'z kapitaliga nisbati Marinus Pharma MRNS|NKGN (NKGen Biotech, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|neurobopharma.com (NRBO) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Sage Therapeutics (SAGE)|Uzoq muddatli qarzning o'z kapitaliga nisbati SNPX (Synaptogenix Inc.)|Trevena, Inc - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti WENA|CERE - Uzoq muddatli qarzning o'z kapitaliga nisbati